+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
TTFL TTFL

Trident Texofab Share Price

₹21.03 +0.08 (0.38%)
94.45% Fall from 52W High

01 Oct, 2026 4:01 PM (IST)

Trident Texofab live price: ₹21.03. It opened at ₹21 vs previous close ₹21; intraday high/low: ₹21/₹21. The 50 & 200 DMA stand at ₹25.00/₹79.20.

Trident Texofab Performance

  • Today's Low
  • ₹21
  • Today's High
  • ₹21
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹379
  • Open Price₹21
  • Previous Close₹21
  • Volume15,991
  • 50 DMA₹25.00
  • 100 DMA₹39.80
  • 200 DMA₹79.20

Trident Texofab Chart

Investment Returns

  • Over 1 Month -9.7%
  • Over 3 Month -41.58%
  • Over 6 Month -54.1%
  • Over 1 Year -93.54%

Smart Investing Starts Here Start SIP with Trident Texofab for Steady Growth!

Invest Now

Trident Texofab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 149.8
  • PEG Ratio
  • -1.6
  • Market Cap Cr
  • 32
  • P/B Ratio
  • 0.6
  • Average True Range
  • 1.5
  • EPS
  • 0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.9
  • RSI
  • 39.55
  • MFI
  • 54.14

Latest Stock News Updates

Trident Texofab Ltd - 540726 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting and e-voting during AGM of the Company held on Wednesday, September 30, 2026 (commenced at 04:00 p.m. and concluded at 04:20 p.m.) through Video Conferencing (VC) / Other Audio Video Means (OAVM).

Trident Texofab Ltd - 540726 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from October 01, 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter and half year ended September 30, 2026

Trident Texofab Ltd - 540726 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Further to our letter dated September 08, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we enclose herewith summary of proceedings of 18th Annual General Meeting (AGM) of members of Trident Texofab Limited held on Wednesday, September 30, 2026 at 04:00 p.m., through Video Conferencing (VC) / Other Audio Video Means (OAVM) facility.

Trident Texofab Financials

Trident Texofab Technicals

EMA & SMA

Current Price
₹21.03
+ 0.08 (0.38%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹21.70
  • 50 Day
  • ₹25.00
  • 100 Day
  • ₹39.80
  • 200 Day
  • ₹79.20

Resistance and Support

20.98 Pivot Speed
  • R3 22.00
  • R2 21.70
  • R1 21.20
  • S1 20.30
  • S2 20.00
  • S3 19.40

Trident Texofab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-10 Quarterly Results
2026-05-30 Audited Results (Revised)
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results (Revised)

Trident Texofab Shareholding Pattern

67.85%
32.16%
0%

Trident Texofab FAQs

Trident Texofab share price is ₹21 As on 02 October, 2026 | 05:13

The Market Cap of Trident Texofab is ₹31.5 Cr As on 02 October, 2026 | 05:13

The P/E ratio of Trident Texofab is 149.8 As on 02 October, 2026 | 05:13

The PB ratio of Trident Texofab is 0.6 As on 02 October, 2026 | 05:13

The 52 week High & Low of Trident Texofab is ₹379/₹20 respectively As on 02 October, 2026 | 05:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23